Episode Details
Back to EpisodesIzalontamab Brengitecan Advances Milestones, Bedrock Feeds Southern Ocean Iron, HPV Vaccine Protects for 18 Years, Mosquito Blood Preference Traced, and more...
Published 1 month, 3 weeks ago
Description
(0:10): Izalontamab Brengitecan Hits Key Milestones in Advanced Breast Cancer Trial, Investors Remain Cautious
(2:50): Rutgers Study Reveals Bedrock, Not Glaciers, as Key Iron Source to Southern Ocean
(5:20): New Study Confirms Long-Term HPV Vaccine Protection Against Cervical Cancer Over 18 Years
(7:42): Mosquito Evolution: Human Blood Preference Originated 1.8 Million Years Ago with Homo Erectus
(9:48): Eli Lilly's New Pill Shows Promise in Revolutionizing Type 2 Diabetes and Weight Management
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
(2:50): Rutgers Study Reveals Bedrock, Not Glaciers, as Key Iron Source to Southern Ocean
(5:20): New Study Confirms Long-Term HPV Vaccine Protection Against Cervical Cancer Over 18 Years
(7:42): Mosquito Evolution: Human Blood Preference Originated 1.8 Million Years Ago with Homo Erectus
(9:48): Eli Lilly's New Pill Shows Promise in Revolutionizing Type 2 Diabetes and Weight Management
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.